日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

鉴定用于治疗 T 细胞淋巴瘤的高活性抗 CCR4 CAR T 细胞

Keisuke Watanabe, Angela M Gomez, Shunichiro Kuramitsu, Mikko Siurala, Tong Da, Sangya Agarwal, Decheng Song, John Scholler, Antonia Rotolo, Avery D Posey, Alain H Rook, Paul L Haun, Marco Ruella, Regina M Young, Carl H June

Potentiating adoptive cell therapy using synthetic IL-9 receptors

利用合成 IL-9 受体增强过继细胞疗法

Anusha Kalbasi #, Mikko Siurala #, Leon L Su #, Mito Tariveranmoshabad, Lora K Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V Kremer, Amy L Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C Rommel, Enrico Radaelli, Regina M Young, 

Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors

出版商更正:利用合成IL-9受体增强过继细胞疗法

Kalbasi, Anusha; Siurala, Mikko; Su, Leon L; Tariveranmoshabad, Mito; Picton, Lora K; Ravikumar, Pranali; Li, Peng; Lin, Jian-Xin; Escuin-Ordinas, Helena; Da, Tong; Kremer, Sarah V; Sun, Amy L; Castelli, Sofia; Agarwal, Sangya; Scholler, John; Song, Decheng; Rommel, Philipp C; Radaelli, Enrico; Young, Regina M; Leonard, Warren J; Ribas, Antoni; June, Carl H; Garcia, K Christopher

Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1

细胞因子编码溶瘤腺病毒TILT-123作为单一疗法以及与免疫检查点抑制剂抗PD-1联合使用,均安全、选择性强且有效。

Havunen, Riikka; Kalliokoski, Riikka; Siurala, Mikko; Sorsa, Suvi; Santos, João M; Cervera-Carrascon, Victor; Anttila, Marjukka; Hemminki, Akseli

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

溶瘤腺病毒塑造卵巢肿瘤微环境,从而增强肿瘤浸润淋巴细胞的肿瘤反应性。

Santos, João Manuel; Heiniö, Camilla; Cervera-Carrascon, Victor; Quixabeira, Dafne C A; Siurala, Mikko; Havunen, Riikka; Butzow, Ralf; Zafar, Sadia; de Gruijl, Tanja; Lassus, Heini; Kanerva, Anna; Hemminki, Akseli

Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors

用于增强实体肿瘤T细胞治疗的临床相关溶瘤病毒平台的比较

Victor Cervera-Carrascon, Dafne C A Quixabeira, Riikka Havunen, Joao M Santos, Emma Kutvonen, James H A Clubb, Mikko Siurala, Camilla Heiniö, Sadia Zafar, Teija Koivula, Dave Lumen, Marjo Vaha, Arturo Garcia-Horsman, Anu J Airaksinen, Suvi Sorsa, Marjukka Anttila, Veijo Hukkanen, Anna Kanerva, Aksel

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

通过工程化的溶瘤腺病毒重塑肿瘤微环境可改善 PD-L1 抑制的效果

Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki

Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy

编码白细胞介素 2 和肿瘤坏死因子 α 的腺病毒在过继 T 细胞治疗中取代淋巴细胞清除化疗

João Manuel Santos, Víctor Cervera-Carrascon, Riikka Havunen, Sadia Zafar, Mikko Siurala, Suvi Sorsa, Marjukka Anttila, Anna Kanerva, Akseli Hemminki

TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade

TNFα和IL-2武装的腺病毒可通过抗PD-1检查点阻断实现完全免疫应答

Cervera-Carrascon, V; Siurala, M; Santos, J M; Havunen, R; Tähtinen, S; Karell, P; Sorsa, S; Kanerva, A; Hemminki, A

Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses

采用间皮素重定向嵌合抗原受体T细胞和细胞因子武装溶瘤腺病毒联合治疗胰腺癌

Keisuke Watanabe ,Yanping Luo ,Tong Da ,Sonia Guedan ,Marco Ruella ,John Scholler ,Brian Keith ,Regina M Young ,Boris Engels ,Suvi Sorsa ,Mikko Siurala ,Riikka Havunen ,Siri Tähtinen ,Akseli Hemminki ,Carl H June